+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 85Years
All Genders
ID06166407

The Breisgau Pheno Heart Study Observing Immune Response and Outcomes After Myocardial Infarction

Led by University Hospital Freiburg · Updated on 2026-10-27

400

Participants Needed

1

Research Sites

313 weeks

Total Duration

AI-Summary

What This Trial Is About

Coronary heart disease and its acute complication, myocardial infarction MI, are leading causes of death in Europe and the United States. This research aims to establish a well-characterized group of patients after MI to identify new cellular and immune biomarkers that could help predict patient risk and guide future treatments. It focuses on understanding the immune response after MI, especially the role of various immune cells and their link to clinical outcomes, which is not well studied in humans. Patients with STEMI or NSTEMI who undergo emergency coronary angiography within 24 hours after MI will be recruited. There is no intervention in this observational study. Participants will be followed with study visits at 6 weeks, 3 months, and 12 months after the initial event. Blood samples will be collected to analyze immune cells and plasma, which will be stored for further research. Clinical data like patient history, exams, ECG, echocardiography, and for some, MRI, will be collected. During the study, participants will undergo detailed clinical assessments and blood tests at the scheduled visits. Major adverse cardiac events such as myocardial infarction, stroke, hospitalization for heart failure, and cardiovascular death will be tracked through interviews and official records. Laboratory analyses will include advanced immune cell profiling and sequencing techniques. The study plans to recruit 400 patients and compare outcomes with a matched control group, with a total study duration extending up to 2034.

CONDITIONS

Brief Title

Breisgau PHENO-HEART MI

Research Team

P

Patrick M Siegel, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here